Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity by Leach, Michelle D et al.
INVESTIGATION
Candida albicans Is Resistant to Polyglutamine
Aggregation and Toxicity
Michelle D. Leach,*,† TaeHyung Kim,‡,§ Sonja E. DiGregorio,** Cathy Collins,† Zhaolei Zhang,†,‡
Martin L. Duennwald,**,1 and Leah E. Cowen†,1
*Aberdeen Fungal Group, University of Aberdeen, Institute of Medical Sciences, Foresterhill, AB25 2ZD, UK,
†Department of Molecular Genetics, University of Toronto, Ontario M5S 1A8, Canada, ‡Banting and Best Department of
Medical Research, The Donnelly Centre, University of Toronto, Ontario, M5S 3E1, Canada, §Department of Computer
Science, University of Toronto, Ontario M5S 2E4, Canada, and **Department of Pathology, Schulich School of Medicine
and Dentistry, University of Western Ontario, London, Ontario N6A 5C1, Canada
ABSTRACT Disruption of protein quality control can be detrimental, having toxic effects on single cell
organisms and contributing to neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Hunting-
ton’s in humans. Here, we examined the effects of polyglutamine (polyQ) aggregation in a major fungal
pathogen of humans, Candida albicans, with the goal of identifying new approaches to disable this fungus.
However, we discovered that expression of polyQ stretches up to 230Q had no effect on C. albicans ability
to grow and withstand proteotoxic stress. Bioinformatics analysis demonstrates that C. albicans has a
similarly glutamine-rich proteome to the unicellular fungus Saccharomyces cerevisiae, which exhibits polyQ
toxicity with as few as 72Q. Surprisingly, global transcriptional proﬁles indicated no signiﬁcant change upon
induction of up to 230Q. Proteomic analysis highlighted two key interactors of 230Q, Sis1 and Sgt2;
however, loss of either protein had no additional effect on C. albicans toxicity. Our data suggest that C.
albicans has evolved powerful mechanisms to overcome the toxicity associated with aggregation-prone
proteins, providing a unique model for studying polyQ-associated diseases.
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All cells use elaborate strategies tomaintain cellular protein homeostasis
and copewith environmental challenges. During stress, protein homeo-
stasis is often compromised, eliciting protein unfolding,misfolding, and
aggregation.Major cellular pathways controlling proteostasis in eukaryo-
tic cells include the heat shock response (HSR) and the unfolded protein
response (UPR), which involvemolecular chaperones that aid in proper
protein folding and prevent protein misfolding (Frydman 2001; Leach
and Cowen 2014b). Both the HSR and UPR are rapidly activated upon
stress to restore homeostasis and thereby prevent the toxic conse-
quences of protein misfolding. Numerous neurodegenerative diseases
are characterized by the accumulation of toxicmisfolded proteins and a
malfunctioning protein quality control system (Ross and Poirier 2004;
Thomas et al. 1995). For example, genetic mutations resulting in aber-
rant expansions of polyQ repeats cause nine neurodegenerative disor-
ders, including Huntington’s disease and spinocerebellar ataxias (Fan
et al. 2014). In all these diseases, CAG trinucleotide repeat expan-
sions in the translated region of speciﬁc genes lead to polyQ length-
dependent aggregation, toxicity, and eventually neurodegeneration
(Duyao et al. 1993).
PolyQ expansion proteins misfold into b sheet-rich, aggregating
structures (Wickner et al. 2007), which mediate abnormal interactions
with other proteins via exposed hydrophobic surfaces, thus leading to
functional impairment and cellular toxicity (Chiti and Dobson 2006;
Bolognesi et al. 2010; Olzscha et al. 2011). The presence of coiled-coil
domains in polyQ peptides, which regulate polyQ aggregation and in-
solubility, are thought to enhance the pathogenesis of polyQ expansion
diseases (Fiumara et al. 2010). PolyQ aggregation is thought to interfere
with cellular protein quality control, including protein degradation,
molecular chaperone-mediated protein folding, and the activity of
the HSR and the UPR, thereby propagating protein misfolding within
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n Table 1 C. albicans strains
Strain Genotype Source
SN95 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434 Noble and Johnson (2005)
CaLC3067 HSP104/HSP104-GFP arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
HSP104/HSP104-GFP
This study
CaLC3069 25Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
HSP104/HSP104-GFP, ADH1/adh1::Ptet-FLAG-25Q-RFP
This study
CaLC3070 25Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
HSP104/HSP104-GFP, ADH1/adh1::Ptet-FLAG-25Q-RFP
This study
CaLC3069 72Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
HSP104/HSP104-GFP, ADH1/adh1::Ptet-FLAG-72Q-RFP
This study
CaLC3070 72Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
HSP104/HSP104-GFP, ADH1/adh1::Ptet-FLAG-72Q-RFP
This study
CaLC3252 103Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC3253 103Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC3256 230Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC3257 230Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
W303a a can1-100, his3-11,15, leu2-3,112, trp1-1, ura3-1, ade2-1 Duennwald et al. (2006b)
25Q As W303a GAL-FLAG-25Q-CFP Duennwald et al. (2006b)
72Q As W303a GAL-FLAG-72Q-CFP Duennwald et al. (2006b)
103Q rnqD As W303a GAL-FLAG-103Q-CFP rnqD Duennwald et al. (2006b)
103Q RNQ As W303a GAL-FLAG-103Q-CFP RNQ Duennwald et al. (2006b)
CaLC4012 hsp104D/hsp104D arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
hsp104D/hsp104D::FRT
This study
CaLC4088 hsp104D/hsp104D
+103Q-1
arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
hsp104D/hsp104D::FRT, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4082 hsp104D/hsp104D
+103Q-2
arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
hsp104D/hsp104D::FRT, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4083 hsp104D/hsp104D
+230Q-1
arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
hsp104D/hsp104D::FRT, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC4084 hsp104D/hsp104D
+230Q-2
arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3:: limm434 IRO1/iro1::limm434
hsp104D/hsp104D::FRT, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC4385 sgt2D/sgt2D arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sgt2D/sgt2D::FRT
This study
CaLC4397 sgt2D/sgt2D+103Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sgt2D/sgt2D::FRT, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4398 sgt2D/sgt2D+103Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sgt2D/sgt2D::FRT, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4399 sgt2D/sgt2D+230Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sgt2D/sgt2D::FRT, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC4400 sgt2D/sgt2D+230Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sgt2D/sgt2D::FRT, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC4450 sis1D/sis1D arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sis1D/sis1D::FRT
This study
CaLC4462 sis1D/sis1D+103Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sis1D/sis1D::FRT, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4463 sis1D/sis1D+103Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sis1D/sis1D::FRT, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4464 sis1D/sis1D+230Q-1 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sis1D/sis1D::FRT, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC4465 sis1D/sis1D+230Q-2 arg4Δ/arg4Δ his1Δ/his1Δ URA3/ura3::imm434 IRO1/iro1::imm434
sis1D/sis1D::FRT, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC3491 BWP17 + CIp30 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, CIp30 (ARG4, HIS1, URA3)
This study
CaLC4483 BWP17+103Q-1 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, CIp30 (ARG4, HIS1, URA3), ADH1/adh1::
Ptet-FLAG-103Q-RFP
This study
CaLC4484 BWP17+103Q-2 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, CIp30 (ARG4, HIS1, URA3),
ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
(continued)
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cells and entire tissues with toxic consequences (Bence et al. 2001;
Gidalevitz et al. 2006).
Much of our understanding of polyQ-mediated toxicity and its
interactions with cellular protein quality control comes from exper-
iments expressing amino-terminal fragments of huntingtin (Htt)-
containing polyQ expansions in the yeast Saccharomyces cerevisiae
(Duennwald et al. 2006a,b; Krobitsch and Lindquist 2000). While only
a small fraction of human proteins contain polyQ domains (deﬁned as
more than 10 consecutive glutamines in a protein), the yeast proteome
is comparatively Q-rich (Michelitsch and Weissman 2000), with more
than 50 polyQ proteins (Krobitsch and Lindquist 2000). Another or-
ganism that harbors unusually high numbers of polyQ proteins is the
social amoeba Dictyostelium discoideum (Malinovska et al. 2015),
which has an exceptionally high level of resilience to polyQ aggregation
and toxicity in the absence of cellular stress (Malinovska et al. 2015;
Santarriaga et al. 2015). As a consequence, D. discoideum was thought
to exemplify the evolution of robust protein quality control machinery
to cope with a proteome enriched in aggregation-prone proteins.
We aimed tounderstandhow themajor fungal pathogen of humans,
Candida albicans, responds to polyQ proteins. C. albicans is a natural
commensal of the human mucosal microbiota; however, in immuno-
compromised patients it can disseminate, accounting for over 400,000
life threatening infections world-wide every year (Horn et al. 2009).
With limited drugs available and antifungal drug resistance on the rise
(Pfaller 2012), we aimed to explore cellular protein quality control inC.
albicans and its potential as a new therapeutic target. To this end, we
expressed polyQ expansion proteins in C. albicans and assessed polyQ
aggregation and toxicity. Our experiments document that C. albicans,
whose proteome has a similar polyQ content to that of S. cerevisiae, is
remarkably resistant to both polyQ aggregation and toxicity. Indeed,
expression of expanded polyQ regions up to 230Qs had no effect on
global transcription, resistance to stress, or general ﬁtness of C. albicans
cells. Heat shock and other proteotoxic stress conditions induced weak
polyQ aggregation, without any toxic consequences. Our results, to-
gether with studies in S. cerevisiae, Schizosaccharomyces pombe, Dro-
sophila melanogaster, Caenorhabditis elegans, and other model
organisms, reveal that the prevalence of aggregation-prone proteins
in an organism’s proteome does not automatically determine the ca-
pacity of the accompanying cellular protein quality control machinery
to modulate protein aggregation and toxicity.
MATERIALS AND METHODS
Strains and growth conditions
All strains are listed in Table 1. C. albicans strains were grown in YPD
(1% yeast extract, 2% bactopeptone, and 2% glucose) (Sherman 1991).
To induce expression of Htt polyglutamine expansions, strains grown
overnight in YPD at 30 were diluted to OD600 0.2 in the absence or
presence of 50 mg/ml doxycycline (BD Biosciences) for 24 hr. Cells
were again diluted to OD600 0.05 under the same conditions and
grown to midlog phase at the temperature indicated (6 hr) prior
to microscopy, RNA extraction, spotting assays, Western blots, or
semidenaturating detergent agarose gel electrophoresis (SDD-AGE)
(Halfmann and Lindquist 2008). S. cerevisiae strains were grown in
selectivemedia containing 2% glucose overnight before being diluted to
OD600 0.2 in selective media containing 2% glucose or 2% galactose to
midlog phase (7 hr) to induce expression of the Htt polyglutamine
expansions. A 30–42, heat shock was imposed as described previously
(Leach et al. 2012c). All drugs were added at the concentrations stated.
Plasmid construction
To generate C. albicans strains expressing various lengths of Htt-PolyQ
repeats, two approaches were taken based on the size of the repeats.
FLAG-HTT-25PolyQ and FLAG-HTT-72PolyQ were PCR ampli-
ﬁed from Met-FLAG-25PolyQ-CFP and Met-FLAG-72PolyQ-CFP
(Duennwald et al. 2006b), using oligos oLC3001/3035. oLC3001 con-
tained three mutations for CUG codon optimization of the Htt gene for
C. albicans. In addition, RFP was PCR ampliﬁed from pLC435
(Keppler-Ross et al. 2008), using primers oLC3011/3036. A fusion
PCR was then performed with oLC3001/3011 to fuse FLAG-HTT-
25PolyQ or 72PolyQ with RFP. The product, along with the plasmid
pNIM1, which contains the tetracycline ON promoter (Park and
Morschhauser 2005), was digested with SalI and BglII. Digested
product and vector were ligated using T4 DNA ligase (NEB) and
n Table 1, continued
Strain Genotype Source
CaLC4485 BWP17+230Q-1 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, CIp30 (ARG4, HIS1, URA3),
ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC4486 BWP17+230Q-2 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, CIp30 (ARG4, HIS1, URA3),
ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC2369 ubi4D/ubi4D ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, UBI4/loxP-HIS1-loxP::ubi4D/loxP-URA-loxP::
ubi4D, NRG1-3xHA-ARG4
This study
CaLC4487 ubi4D/ubi4D +103Q-1 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, UBI4/loxP-HIS1-loxP::ubi4D/loxP-URA-loxP::
ubi4D, NRG1-3xHA-ARG4, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4488 ubi4D/ubi4D +103Q-2 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG
his1D::hisG/his1D::hisG, UBI4/loxP-HIS1-loxP::ubi4D/ loxP-URA-loxP::
ubi4D, NRG1-3xHA-ARG4, ADH1/adh1::Ptet-FLAG-103Q-RFP
This study
CaLC4489 ubi4D/ubi4D +230Q-1 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG his1D::hisG/
his1D::hisG, UBI4/loxP-HIS1-loxP::ubi4D/ loxP-URA-loxP::ubi4D,
NRG1-3xHA-ARG4, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
CaLC4490 ubi4D/ubi4D +230Q-2 ura3D::imm434/ura3D::imm434 arg4D::hisG/arg4D::hisG his1D::hisG/
his1D::hisG, UBI4/loxP-HIS1-loxP::ubi4D/ loxP-URA-loxP::ubi4D,
NRG1-3xHA-ARG4, ADH1/adh1::Ptet-FLAG-230Q-RFP
This study
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transformed into TOP10 cells (Invitrogen). Correct integration was
tested for by PCR using oligos oLC3012/3013 (350 bp for 25PolyQ
and 491 bp for 72PolyQ), and oLC3014/3015 (345 bp). This generated
plasmids pLC774, tetON-FLAG-25PolyQ-RFP and pLC775, tetON-
FLAG-72PolyQ-RFP. Plasmids were sequenced using oLC3012/3015.
Due to the nature of PolyQ repeats in generating 103Q and 230Q
repeats, the FLAG-HTT-103PolyQ-RFP and FLAG-HTT-230PolyQ-
RFPwere synthesized (Invitrogen). The constructs and plasmid pNIM1
were liberated by digestion with BglII and SalI, gel puriﬁed, ligated, and
transformed into Stbl2 cells (Invitrogen). Upstream integration was
tested by PCR using oligos oLC3012/3013, with an expected size of
583 bp for 103PolyQ and 964 bp for 230PolyQ. Downstream integra-
tion was tested by PCR using oligos oLC3014/3015 with an expected
size of 345 bp. This generated plasmids pLC807, tetON-FLAG-
103PolyQ-RFP and pLC814, tetON-FLAG-230PolyQ-RFP. Plasmids
were sequence veriﬁed using oLC3012/3036/3014. Primers are listed
in Supplemental Material, Table S1.
Strain construction
C. albicans strains expressing 25Q and 72Qwere generated by digesting
pLC774 (25Q) or pLC775 (72Q) with ApaI and SacII to liberate the
cassette. Cassettes were transformed into CaLC3067. NAT-resistant
transformants were PCR tested for correct integration at the ADH1
locus by amplifying across both junctions using primer pairs oLC452/
453 and oLC454/455. This generated CaLC3069 (25Q-1), CaLC3070
(25Q-2), CaLC3071 (72Q-1), and CaLC3072 (72Q-2).
To generate strains expressing 103Q or 230Q, pLC807 (103Q) or
pLC814 (230Q) were digested with ApaI and SacII to liberate the
cassettes. Constructs were transformed into SN95 (CaLC239). NAT-
resistant transformants were PCR tested for correct integration at the
ADH1 locus by amplifying across both junctions using primer pairs
oLC452/453 and oLC454/455. This generated CaLC3252 (103Q-1),
CaLC3253 (103Q-2), CaLC3256 (230Q-1), and CaLC3257 (230Q-2).
To generate an hsp104D/hsp104Dmutant, the ﬁrst allele ofHSP104
was deleted by PCR amplifying the NAT ﬂipper cassette (pLC49) with
oLC3967/3968 containing homology to sequence upstream and down-
stream of HSP104. The PCR product was transformed into SN95
(CaLC239) and NAT-resistant transformants were PCR tested with
oLC275/3021 and oLC274/3969 to verify integration of the cassette.
The NAT cassette was excised, and a second round of transformation
was performed to delete the second allele, using the same PCR product
as was used to delete the ﬁrst allele. Veriﬁcation of deletion was ascer-
tained as described above, and loss of the wild-type allele was deter-
mined by PCR using oligos oLC782/785. The NAT cassette was then
excised, generating CaLC4012. The 103Q and 230Q constructs were
transformed into this background as described above, generating
CaLC4088 (hsp104D/hsp104D + 103Q-1), CaLC4082 (hsp104D/
hsp104D + 103Q-2), CaLC4083 (hsp104D/hsp104D + 230Q-1), and
CaLC4084 (hsp104D/hsp104D + 230Q-2).
To generate an sgt2D/sgt2D mutant, the ﬁrst allele of SGT2 was
deleted by PCR amplifying the NAT ﬂipper cassette (pLC49) with
oLC4197/4198 containing sequence homology upstream and down-
stream of SGT2. The PCR product was transformed into SN95
(CaLC239), and NAT-resistant transformants were PCR tested with
oLC275/4199 and oLC274/4200 to verify integration of the cassette.
The NAT cassette was excised, and a second round of transformation
was performed to delete the second allele, using the same PCR product
as was used to delete the ﬁrst allele. Veriﬁcation of deletion was ascer-
tained as described above, and loss of the wild-type allele was deter-
mined by PCR using oligos oLC4201/4202. The NAT cassette was then
excised, generating CaLC4385. The 103Q and 230Q constructs were
transformed into this background as described above, generating
CaLC4397 (sgt2D/sgt2D + 103Q-1), CaLC4398 (sgt2D/sgt2D + 103Q-
2), CaLC4399 (sgt2D/sgt2D + 230Q-1), and CaLC4400 (sgt2D/sgt2D +
230Q-2).
To generate a sis1D/sis1Dmutant, the ﬁrst allele of SIS1was deleted
by PCR amplifying the NAT ﬂipper cassette (pLC49) with oLC4270/
4271 containing sequence homology upstream and downstream of
SIS1. The PCR product was transformed into SN95 (CaLC239) and
NAT-resistant transformants were PCR tested with oLC275/4272 and
oLC274/4273 to verify integration of the cassette. TheNAT cassettewas
excised, and a second round of transformation was performed to delete
the second allele, using the same PCR product as was used to delete the
ﬁrst allele. Veriﬁcation of deletion was ascertained as previously de-
scribed, and loss of the wild-type allele was determined using oligos
oLC4378/4379. The NAT cassette was then excised, generating
CaLC4450. The 103Q and 230Q constructs were transformed into this
background as described above, generating CaLC4462 (sis1D/sis1D +
103Q-1), CaLC4463 (sis1D/sis1D + 103Q-2), CaLC4464 (sis1D/sis1D +
230Q-1) and CaLC4465 (sis1D/sis1D + 230Q-2).
A ubi4D/ubi4D mutant had already been generated in the BWP17
background (Leach et al. 2011). As such, the 103Q and 230Q constructs
were transformed into this background as described above, generating
CaLC4483 (BWP17 + 103Q-1), CaLC4484 (BWP17 + 103Q-2),
CaLC4485 (BWP17 + 230Q-1) and CaLC4486 (BWP17 + 230Q-2),
CaLC4487 (ubi4D/ubi4D + 103Q-1), CaLC4488 (ubi4D/ubi4D +
103Q-2), CaLC4489 (ubi4D/ubi4D + 230Q-1), and CaLC4490
(ubi4D/ubi4D + 230Q-2).
Spotting and liquid assays
The spotting assay was performed with two independent strains of
induced cells, grown at the temperature indicated, by determining
OD600, diluting cells to an equal concentration, and spotting 10-fold
dilutions (from 1 · 106 cells/ml) onto YPD. Plates were imaged after
48 hr. All spotting assays were performed in duplicate on at least two
separate occasions. The liquid assays were performed in ﬂat bottom,
96-well microtiter plates (Sarstedt). Cell densities of overnight cultures
were determined and dilutions were prepared such that103 cells were
inoculated into eachwell. Assays were set up in a total volume of 0.2ml/
well of YPD or YPD containing 50 mg/ml doxycycline with twofold
dilutions of the following drugs: Azetidine-2-carboxylic acid (Sigma,
A0760), guanidine hydrochloride (Sigma, G4505), tunicamycin (Sigma,
T7765), MG132 (Sigma, C2211), or geldanamycin (LC Labs, 4500).
Plates were incubated in the dark at 30 or 42 for 48 hr, at which point
plates were sealed and resuspended by agitation. Absorbance was de-
termined at 600 nm using a spectrophotometer (Molecular Devices)
and was corrected for background from the corresponding medium.
Assays were performed in duplicate on at least two occasions. MIC data
were quantitatively displayed with color using the program Java Tree-
View 1.1.3 (http://jtreeview.sourceforge.net).
SDD-AGE
Strains were grown as described in the growth conditions section.
Midlog phase cells were harvested, washed once with dH2O, and snap
frozen in liquid nitrogen. Cells were lysed in 300 ml lysis buffer
(100 mM Tris pH 7.5, 200 mM NaCl, 1 mM EDTA, 5% glycerol,
1 mM DTT, 8 mM PMSF, and protease inhibitor cocktail), and
200 mg of 0.5 mm acid-washed beads was added to each tube. Cells
were mechanically disrupted on a Biospec Mini-Beadbeater for six
30 sec periods, with 1 min on ice between each cycle. A 26G syringe
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was used to puncture the bottom of the tube, and supernatant was
collected by spinning for 1 min at 5000 rpm. Protein was quantiﬁed
using a Bradford assay. Gel was prepared by dissolving 1.5% agarose in
1 · TAE and, once dissolved, SDS was added at 0.5%. Running buffer
was 1 · TAE with 0.5% SDS. Samples were prepared in 4 · sample
buffer (2 · TAE, 20% glycerol, 8% SDS, and bromophenol blue) at 1 ·
and boiled for 5min at 100. Samples were run at 50V for3.5 hr. Gels
were rinsed in dH2O and then TBS (20 mM Tris pH 7.5 and 9 g NaCl
up to a volume of 1 L in dH2O), and transferred onto PVDF mem-
branes using Whatman: Turboblotter Rapid Downward Transfer Sys-
tems for 5 hr.Membranes were blocked and proteins detected as per the
western blotting protocol.
Microscopy
Imaging was performed on a Zeiss Imager M1 upright microscope and
AxioCam MRm with AxioVision 4.7 software (Carl Zeiss, Inc.). An
X-Cite series120 light source with ET HQ tetramethylrhodamine
isothiocyanate (TRITC)/DsRED ﬁlter sets from ChromaTechnology
(Bellows Falls, VT) was used for ﬂuorescence microscopy.
Dot blots
Dot blots were performed as described before (Cashikar et al. 2005). In
brief, protein lysates were prepared using glass beads and lysis buffer
[100mMTris PH 7.5, 200 mMNaCl, 1 mMEDTA, 5% glycerol, 1 mM
DTT, 4mMPMSF, and protease inhibitor tablet (Sigma)]. Lysates were
normalized using BCA and diluted in phosphate-buffered saline (PBS)
in threefold serial dilutions. All dilutions were loaded onto the BIO-
DOT apparatus (Bio-Rad), and assembled with a 0.2 mm nitrocellulose
membrane. A vacuumwas applied to themanifold to transfer the lysate
from the apparatus to the membrane. Membrane was then probed with
a 1:5000 anti-FLAG antibody or 1:10,000 anti-PSTAIRE antibody and
processed as a western blot.
Quantitative RT-PCR
Cells were grown as stated in the growth conditions section. At midlog
phase, strains were subjected to a 10min 30–42 heat shock as described
previously (Leach and Cowen 2014a), or left untreated at 30. Cells
were harvested from each culture, centrifuged at 3000 rpm for 2 min at
4, and washed once with dH2O, before being snap frozen in liquid
nitrogen and stored at280. RNA was subsequently isolated using the
QIAGEN RNeasy kit and cDNA synthesis was performed using the
AfﬁnityScript cDNA synthesis kit (Stratagene). PCR was carried out
using the SYBR Green JumpStart Taq ReadyMix (Sigma) with the
following cycle conditions: 95 for 3 min, 95 for 10 sec and 60 for
30 sec for 39 rounds, 95 for 10 sec, and 65 for 5 sec. Reactions were
performed in triplicate using the following primer pairs: HSP104
(oLC1620/1621) andHSP90 (oLC756/757). Transcript levels were nor-
malized to ACT1 (oLC2285/2286). Data were analyzed using the Bio-
Rad CFX Manager software, version 3.1 (Bio-Rad).
Western blotting
Total soluble protein was extracted and subjected to western blotting
using published protocols (Leach and Cowen 2014a). Brieﬂy, midlog-
phase cells were pelleted by centrifugation, washed with sterile water,
and resuspended in lysis buffer [0.1M Tris-HCl (pH 8.0), 10% glycerol,
1 mM DTT, 1 mM PMSF, and protease inhibitor cocktail]. An equal
volume of 0.5 mm acid-washed beads was added to each tube and cells
were mechanically disrupted on a Biospec Mini-Beadbeater for six
30 sec periods, with 1 min on ice between each cycle. The lysate was
pelleted by high-speed centrifugation and the supernatant removed for
analysis. Protein concentration was determined by a Bradford assay.
Protein samples were mixed with one-sixth volume of 6 · sample
buffer [0.35 M Tris-HCl, 10% (wt/wt) SDS, 36% glycerol, 5%
b-mercaptoethanol, and 0.012%bromophenol blue], and 75mg protein
was loaded in wells of an 8% SDS-PAGE gel. Separated proteins were
transferred to a PVDF membrane for 1 hr at 100 V at 4. Membranes
were blocked in 5% milk in PBS containing 0.1% Tween 20 (PBS-T) at
room temperature for 1 hr and subsequently incubated in a 1:10,000
dilution of anti-FLAG HRP-conjugated antibody (Sigma, A8592) in
PBS-T + 5% milk [PBS 0.1% Tween-20 and 5% (w/v) milk]. Primary
antibody was left on the membrane for 1 hr at room temperature.
Membranes were washed in PBS-T and signals detected using an
ECL western blotting kit as per the manufacturer’s instructions
(Pierce).
RNA-seq
Wild-type (CaLC239, SN95), 103Q (CaLC3252)-, and 230Q
(CaLC3256)-expressing cells were grown in the absence or presence
of 50 mg/ml doxycycline as described in the growth conditions section,
and RNA was isolated using the Ambion RiboPure RNA puriﬁcation
yeast kit. Three biological replicates grown on three separate occasions
were analyzed. RNA integrity was assayed on an Agilent Bioanalyser
with freshly prepared gel-dye matrix according to the Agilent Bioana-
lyser RNAPico protocol. Ribosomal RNAwas removed using the Ribo-
Zero Gold rRNA Removal Kit and TruSeq RNA-seq libraries were
prepared according to the manufacturer’s instructions (Illumina),
and sequenced on the Illumina HiSeq2000 platform. The sequencing
data were assessed for quality using FastQC (http://www.bioinfor-
matics.babraham.ac.uk/projects/fastqc/). All 51 bases for all 18 samples
(six samples per biological replicate) had a minimum median Phred
quality score over 32 (around 99.94% base call accuracy). The number
of reads for each sample ranged from 12.3M reads to 17.0M reads with
a minimummapping rate of 95.9%. Each read was mapped against a C.
albicans reference genome (SC5314, A21) using Tophat2 (version
2.1.0) with maximum mismatch of 1 and a gene transfer ﬁle (-N 1)
(Kim et al. 2013), then expression of each RNA transcript was quan-
tiﬁed and compared using cufﬂinks and cuffdiff (version 2.2.1) with the
default setting (Trapnell et al. 2013). Both the reference genome and
transcript annotation were downloaded from the Candida Genome
Database (Inglis et al. 2012). All sequencing data are deposited at the
Sequence Read Archive (Study Accession: SRP073330).
Detection of polyQ interactors
Untaggedwild-type (CaLC239, SN95) and 230Q (CaLC3256)-expressing
cells were grown in the absence or presence of 50 mg/ml doxycycline,
as described in the growth conditions section. Cells were harvested at
an OD600 0.8 at 4000 rpm for 10 min at 4, washed twice with ice-cold
1 · PBS, and snap frozen in liquid nitrogen. Cells were resuspended in
10 ml of lysis buffer [20 mM Tris pH 7.5, 100 mM KCl, 5 mM MgCl,
and 20% glycerol, with one protease inhibitor cocktail per 50 ml (com-
plete, EDTA-free tablet, Roche Diagnostics), 1 mM PMSF (EMD
Chemicals), and 0.5% Tween 20]. Cells were disrupted by bead-beating
twice for 4 min with a 7 min break on ice between cycles. Lysates were
centrifuged at 1300 · g for two 5min cycles, recovering the supernatant
at each stage. The combined lysate was centrifuged twice at 21,000 · g,
ﬁrst for 10 min and second for 5 min at 4, and protein concentrations
determined using the Bradford assay. Protein A/G beads (Santa Cruz
SC-2003) were prepared for preclearing as per the manufacturer’s in-
structions, and protein samples were precleared for 1.5 hr at 4 with
end-to-end rotation.
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Anti-FLAG immunoprecipitations were performed by diluting pro-
tein samples to20mg/ml in lysis buffer containing1·TritonX-100, and
incubating in 50 ml anti-FLAG M2 afﬁnity gel (Sigma A2220) at 4
overnight with end-to-end rotation, as per the manufacturer’s speciﬁ-
cations. Protein samples were eluted by washing beads twice with lysis
buffer with detergent followed by three times with lysis buffer without
detergent. Fresh elution buffer (9.5 M NH4OH, pH 11.0–12.0 and
0.5 mM EDTA) was then added at three times the bead volume and
samples incubated at 4 for 15 min with end-over-end rotation. This
was repeated three times. Samples were digested in-solution as de-
scribed previously (Gundry et al. 2009). Brieﬂy, DTT was added to a
ﬁnal concentration of 10 mM and samples were incubated with end-
over-end rotation at room temperature for 30 min. Trypsin (Promega,
MS grade) was added and samples were incubated overnight at 37with
end-over-end rotation. Reactions were stopped by adding 5 ml of 1.0%
TFA.
Samples were analyzed on an Orbitrap analyzer (Q-Exactive,
Thermo Fisher Scientiﬁc, San Jose, CA) outﬁtted with a nanospray
source and EASY-nLC nano-LC system (Thermo Fisher Scientiﬁc).
Lyophilized peptide mixtures were dissolved in 11 ml of 0.1% formic
acid and 5ml were loaded onto a 75mm · 50 cm PepMax RSLC EASY-
Spray column ﬁlled with 2mMC18 beads (Thermo Fisher Scientiﬁc) at
a pressure of 800 Bar. Peptides were eluted over 60 min at a rate of
250 nl/min using a 0–35% acetonitrile gradient in 0.1% formic acid.
Peptides were introduced by nano-electrospray into the Q-Exactive
mass spectrometer (Thermo Fisher Scientiﬁc). The instrument method
consisted of one MS full scan (400–1500 m/z) in the Orbitrap mass
analyzer with an automatic gain control (AGC) target of 1e6,maximum
ion injection time of 120 msec, and a resolution of 70,000 followed by
10 data-dependent MS/MS scans with a resolution of 17,500, an AGC
target of 1e6, maximum ion time of 120 msec, and one microscan. The
intensity threshold to trigger a MS/MS scan was set to 1.7e4. Fragmen-
tation occurred in theHCD trap with normalized collision energy set to
27. The dynamic exclusion was applied using a setting of 10 sec.
Database searching
Tandem mass spectra were extracted, charge state deconvoluted, and
deisotoped by Xcalibur version 2.2. All MS/MS samples were analyzed
using Sequest (Thermo Fisher Scientiﬁc; version 1.4.1.14) and X!
Tandem [The GPM, thegpm.org; version CYCLONE (2010.12.01.1)].
Sequest was set up to searchUniprot-C_albicans.fasta (downloaded Feb
28 2014, 9082 entries) assuming the digestion enzyme trypsin. X!
Tandem was set up to search the Uniprot-C_albicans database (down-
loaded Feb 28 2014, 9082 entries) also assuming trypsin. Sequest and X!
Tandemwere searchedwith a fragment ionmass tolerance of 0.020 kDa
and a parent ion tolerance of 10.0 PPM. Deamidated of asparagine and
glutamine, oxidation of methionine, and carbamidomethyl of cysteine
were speciﬁed in Sequest as variable modiﬁcations. Glu-.pyro-Glu of
the N-terminus, ammonia-loss of the N-terminus, Gln-.pyro-Glu of
the N-terminus, deamidated of asparagine and glutamine, oxidation
of methionine, and carbamidomethyl of cysteine were speciﬁed in X!
Tandem as variable modiﬁcations.
Protein identiﬁcation
Scaffold (version Scaffold_4.5.0, Proteome Software Inc., Portland, OR)
was used to validate MS/MS-based peptide and protein identiﬁcations.
Peptide identiﬁcations were accepted if they could be established at .
95.0% probability. Peptide Probabilities from Sequest were assigned by
the Scaffold Local FDR algorithm. Peptide Probabilities from X! Tan-
demwere assigned by the Peptide Prophet algorithm (Keller et al. 2002)
with Scaffold D-mass correction. Protein identiﬁcations were accepted
if they could be established at . 95.0% probability, contained at least
one identiﬁed peptide, and were present in both biological replicates.
Protein probabilities were assigned by the Protein Prophet algorithm
(Nesvizhskii et al. 2003). Proteins that contained similar peptides and
could not be differentiated based on MS/MS analysis alone were
grouped to satisfy the principles of parsimony. Proteins sharing signif-
icant peptide evidence were grouped into clusters. The mass spectrom-
etry data has been deposited into the Proteome Exchange PRIDE
database (http://www.proteomexchange.org/) under the accession
number PXD003916.
Data availability
All sequencing data are deposited at the Sequence Read Archive (Study
Accession: SRP073330). Themass spectrometrydatahas beendeposited
into the Proteome Exchange PRIDE database (http://www.proteomex-
change.org/) under the accession number PXD003916.
RESULTS
Absence of polyQ aggregation and toxicity in
C. albicans
We generated a series of constructs containing human Htt exon 1 with
varying lengths (25Q, 72Q, 103Q, and 230Q) of polyQ tracts (CAG
repeats) with an amino-terminal FLAG tag and a C-terminal Red
Fluorescent Protein (RFP), under the control of the tetracycline ON
promoter, integrated at the ADH1 locus in C. albicans (Figure S1A)
(Park andMorschhauser 2005). Our initial studies focused on 25Q and
72Q, where we examined cells for aggregation and toxicity; 25Q rep-
resents a nondisease related, nontoxic, and nonaggregating polyQ
length, and 72Q represents a highly aggregation-prone and toxic polyQ
length in many different model organisms including S. cerevisiae (Fig-
ure S1B), D. melanogaster, C. elegans, cultured mammalian cells, and
rodents (Burright et al. 1995; Morley et al. 2002; Waelter et al. 2001;
Marsh et al. 2000).
First, we examined PolyQ aggregation by microscopy in cells that
were grown tomidlog phase in the presence of 50mg/ml doxycycline to
induce polyQ expression (Figure S1A). Addition of doxycycline caused
cells containing the polyQ expansions to ﬂuoresce, with the signal
uniformly and evenly distributed throughout the cell for both 25Q
and 72Q. The lack of polyQ aggregation for 72Q suggests that C.
albicans, in contrast to S. cerevisiae and many other organisms, is re-
sistant to polyQ aggregation.
Further,we examinedpolyQ toxicity inC.albicans.Wild-type, 25Q-,
and 72Q- expressing cells were grown at 30 or 42 in the absence and
presence of doxycycline to induce expression of the expanded polyQ
regions, and spotted on YPD plates to assess toxicity (Figure S1C). No
growth defect was observed for any of the strains. Next, we monitored
growth in 96-well plates in the absence and presence of doxycycline
with a gradient of the nucleoside antibiotic tunicamycin, which induces
ER stress and the UPR, and increases polyQ toxicity in S. cerevisiae and
mammalian cells (Wimalasena et al. 2008). Comparable growth was
observed for two independent 25Q- and 72Q-expressing strains and the
wild-type strain under all conditions (Figure S1D). Thus, expression of
72Q does not elicit polyQ toxicity even in the context of ER stress. This
is in contrast to S. cerevisiae, for which induction of 72Q using galactose
causes toxicity compared to wild-type or 25Q-expressing strains (Fig-
ure S1E) (Duennwald et al. 2006b).
Next, we examined very long polyQ expansions, up to 230Q. We
assessed polyQ expression bywestern blot in the absence (no induction)
and presence (induction) of doxycycline. In two independent strains for
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103Qand230Q,weobservedaclear signal in thepresenceofdoxycycline
(Figure 1A), conﬁrming that the polyQ repeats are expressed. This also
indicates solubility of the polyQ expansion proteins in C. albicans, in
contrast to polyQ expression in S. cerevisiae and other organisms, for
which polyQ expansions are unable to migrate in SDS-PAGE due to
insolubility (Krobitsch and Lindquist 2000). To further study the ag-
gregation of these very long polyQ expansions, we performed ﬂuores-
cence microscopy to visualize RFP (Figure 1B). The ﬂuorescence signal
for the 103Q constructs was once again uniformly distributed within
cells, with no obvious punctate structures visible (Figure 1B). Only 8%
of cells expressing 230Q displayed some punctate structures, possibly
indicating rare aggregation beginning in the few cells over the 30 hr
time course of protein induction (Figure 1B).
In order to corroborate our microscopy results, we performed
SDD-AGE assays to characterize polyQ aggregation biochemically in
the 103Q- and 230Q-expressing strains. We included the rnqD and
[RNQ+] 103Q polyglutamine-expanded Htt strains from S. cerevi-
siae, in which strains harboring as short a polyQ expansion as 46Q
are known to be insoluble (Alberti et al. 2009; Chafekar et al. 2012).
Rnq1 in its prion conﬁrmation plays an essential role in polyQ
aggregation, leading to toxicity (Meriin et al. 2002). Since C. albi-
cans lacks prion proteins, we included the rnqD as a suitable control.
In stark contrast to the insoluble protein aggregates observed in S.
cerevisiae 103Q-expressing strains, the 103Q and even 230Q expan-
sions remained completely soluble in C. albicans (Figure 1C). Thus,
in C. albicans, polyQ expansions do not form aggregates detectable
by microscopy or biochemical assays, even with extremely long
polyQ stretches that would readily aggregate in many other eukary-
otic cell types.
We next tested whether the expression of 103Q or 230Q causes
polyQ toxicity, as evidenced by reduced growth inC. albicans. PolyQ
expansions were induced by growing cells for 24 hr, followed by
subculture and growth for an additional 6 hr before plating cells on
YPD in serial dilutions to assess potential growth defects (Figure
2A). All strains grew at similar rates, suggesting that expression of
polyQ proteins with long glutamine regions is not toxic to C. albi-
cans (Figure 2A).
In an attempt to unmask polyQ toxicity, we expressed the polyQ
expansion proteins in the presence of additional proteotoxic stresses.
First, we set up a growth assay in 96-well plates in the presence of
doxycycline to express the expandedpolyQregionswitha concentration
gradient of tunicamycin. We included strains in the absence of doxy-
cycline and the S. cerevisiae wild-type, rnqD, and [RNQ+] 103Q poly-
glutamine-expanded Htt strains as controls. As expected, expression of
the 103Q polyglutamine-expanded Htt in S. cerevisiae [RNQ+] strain
impaired growth compared to wild-type cells lacking the polyQ expan-
sion, with a minor effect seen in the rnqD strain (Figure 2B). In stark
contrast, neither the C. albicans 103Q or 230Q strains exhibited any
Figure 1 Expression of up to 230Q does not cause aggregation in C.
albicans. (A) Western blot analysis using the FLAG epitope of wild-type
(WT) and two independent strains harboring 103Q or 230Q expression
constructs under the control of the tetracycline ON promoter. Protein
expression was monitored after a total of 30 hr induction [2, no doxy-
cycline (dox); +, 50 mg/ml dox]. White arrow = 103Q, black arrow =
230Q. (B) Live cell red ﬂuorescent protein (RFP) (middle) and differen-
tial interference contrast (DIC) (left) microscopy of WT, and strains
harboring 103Q or 230Q expression constructs in the absence (No
dox) or presence (+ dox) of 50 mg/ml dox. Inset: magniﬁcation of a
subset of cells representing polyQ expression. Scale bar, 20 mm. (C)
Semidenaturating detergent agarose gel electrophoresis analysis of
aggregated proteins expressed from S. cerevisiae WT, 103Q in rnqD,
and 130Q in [RNQ+] grown in minimal medium with glucose (not in-
ducing) or galactose (inducing) (lanes 1–6), C. albicansWT, and strains
harboring 103Q or 230Q expression constructs grown in yeast pep-
tone dextrose medium in the absence (2, not inducing) or presence
(+, inducing) of 50 mg/ml dox. Detection via the N-terminal FLAG-tag.
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growth defect (Figure 2B). We further tested other compounds that
perturb protein homeostasis, including the Hsp90 inhibitor gelda-
namycin, the proteasome inhibitor MG132, the protein unfolding
inducer azetidine-2-carboxylic acid, and the Hsp104 inhibitor
guanidine hydrochloride (Figure 2C). Even at very high concentra-
tions, all except geldanamycin had no impact on the growth of wild-
type cells. Expression of up to 230Q had no additional effect on cell
growth, demonstrating that C. albicans does not display polyQ tox-
icity even in the presence of proteotoxic stress (Figure 2C). To
ensure that polyQ Htt protein levels were similar between S. cere-
visiae and C. albicans, we compared polyQ Htt proteins using dot
blots. The 103Q polyglutamine-expanded protein levels in S. cere-
visiae were comparable to the expression levels of 103Q in C. albi-
cans. However, 230Q expression levels in C. albicans were more
than 20-fold higher than 103Q in S. cerevisiae, ruling out the pos-
sibility that the lack of toxicity in C. albicans could be due to low
levels of polyQ expression (Figure 2D).
High temperature induces polyQ aggregation
independent of toxicity
When cells are subjected to a heat shock or continuous growth at
high temperatures, many proteins unfold, which reduces growth
and general ﬁtness (Leach et al. 2012a). We asked whether polyQ
expression combined with growth at high temperature would over-
whelm the protein folding machinery, leading to increased aggre-
gation and toxicity. First, we examined aggregation of our polyQ
Figure 2 Expression of up to 230Q in com-
bination with proteotoxic stressors does not
cause toxicity in C. albicans. (A) Wild-type
(WT) and strains harboring 103Q or 230Q ex-
pression were monitored after a total of 30 hr
induction (2, no doxycycline (dox); +, 50mg/ml
dox) before being serially diluted ten-fold
and spotted onto YPD solid medium, grown
at 30, and imaged after 48 hr. (B) Toxicity of
S. cerevisiaeWT, 103Q in rnqD, and 103Q in
[RNQ+] compared to C. albicans WT and
strains harboring 103Q or 230Q expression
constructs was assessed in the presence of a
tunicamycin (Tm) gradient from 0 to 10 mg/ml,
in twofold dilutions in YPD with (inducing) or
without (not inducing) 50 mg/ml dox or min-
imal medium with glucose (not inducing) or
galactose (inducing). Growth was measured
after 48 hr static incubation by absorbance at
600 nm and normalized relative to the no Tm
control. For each strain, optical densities were
averaged for duplicate measurements and dis-
played quantitatively using Treeview, as shown
in the color bar. Data are representative for
three biological replicates. (C) Toxicity of the
C. albicans strains harboring 103Q and 230Q
was assessed in the presence of proteotoxic
stressors. Gradients were performed in twofold
dilutions, and strains set up in YPD in the ab-
sence (no dox) or presence of 50 mg/ml dox.
Growth was measured after 48 hr static incuba-
tion at 30 by absorbance at 600 nm and nor-
malized relative to the untreated control. AzC,
azetidine-2-carboxylic acid; GdA, geldanamy-
cin; GnHCl, guanidine hydrochloride. (D) Dot
blots were performed to determine the expres-
sion levels of 103Q in S. cerevisiae, and 103Q
and 230Q in C. albicans. Protein lysates were
serially diluted in PBS and loaded on the dot
blot apparatus assembled with a nitrocellulose
membrane. Blot quantiﬁcation was carried out
using Bio-Rad Image Lab 5.2 software following
the blot scan. PolyQ expression levels have
been normalized to the corresponding loading
control (PSTAIRE). S. cerevisiae 103Q was set to
1. 103Q expression in C. albicans is 2.5 times
greater than in S. cerevisiae, and 230Q is
23 times greater. AzC, azetidine-2-carboxylic
acid; GdA, geldanamycin; GnHCl, guanidine
hydrochloride.
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expansions by ﬂuorescence microscopy. PolyQ expansions were in-
duced by growing cells for 24 hr, followed by subculture and growth
for an additional 6 hr at 42 before imaging. The ﬂuorescence signal
for the 103Q constructs was once again evenly distributed through-
out the cell, with only minimal punctate structures visible (Figure
S2A). In contrast, induction of 230Q produced extensive punctate
structures, indicating that the longer polyQ expansions no longer
remain soluble and aggregate.
Based on this result andpreviously publishedwork,wepostulated that
expressing 103Q and 230Q at high temperature with a gradient of the
unfolded protein stressor tunicamycin would unmask polyQ toxicity. To
our surprise, once again, none of the polyQ expressing strains exhibited
any growth defect (Figure S2B). We also tested the unfolded protein
inducer azetidine-2-carboxylic acid and the Hsp104 inhibitor guanidine
hydrochloride on cells incubated at 42. Again, we observed no toxicity
whatsoever in any of the polyQ expressing strains (Figure S2C).
Expression of polyglutamine-expanded Htt has no
effect on the global transcriptional response
Studies in cultured mammalian cells, yeast, and mice, have docu-
mented a strong transcriptional response to the expression of polyQ
expansion proteins (Hughes et al. 2001; Mohan et al. 2014). Given
our ﬁndings of the exceptional resistance of C. albicans to polyQ
aggregation and toxicity, we asked whether the cells effectively upreg-
ulate protective genes, such as molecular chaperones, to prevent
polyQ aggregation and toxic consequences. Speciﬁcally, we tested
whether polyQ expansion proteins activate the HSR, leading to
upregulation of key molecular chaperones that could modulate
polyQ proteins. To this end, we expressed 103Q and 230Q expan-
sions by growing cells for 24 hr, followed by subculture and growth
for an additional 6 hr before subjecting cells to a short 10 min 42
heat shock. Expression of HSP90, a key molecular chaperone known
to aid in the folding of 10% of the proteome (Leach et al. 2012b),
and HSP104, which functions as a potent protein disaggregase
(Grimminger-Marquardt and Lashuel 2010), was then examined.
In the absence of heat shock, there was no difference in HSP90 or
HSP104 transcript levels between wild-type and polyQ-expressing
strains (Figure 3A). Heat shock induced transcript levels of both
genes, as expected, but once again no signiﬁcant difference was
observed between wild-type and polyQ expansion strains (Figure
3A). These experiments indicate that polyQ expression does not
induce a HSR under normal growth conditions, and that C. albicans
Figure 3 Expression of polyQ does not
affect the transcriptome of C. albicans. (A)
C. albicans wild-type (WT) and strains har-
boring 103Q or 230Q expression constructs
were grown at 30 (no heat shock [HS]) or
subjected to a 10 min 30–42 HS, in the
absence (2) and presence (+) of 50 mg/ml
doxycycline (dox) to induce polyQ expres-
sion; transcript levels of target genes were
measured and normalized to the ACT1 load-
ing control. Data represent mean values 6
SD from two independent biological repli-
cates. (B) Heat map illustrating the Pearson
correlation of RNA sequencing (RNA-seq)
global gene expression between WT and
strains harboring 103Q or 230Q expression
constructs in the absence and presence of
50 mg/ml dox to induce polyQ expression.
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cells expressing polyQ proteins elicit a normal HSR, in contrast to S.
cerevisiae and mammalian cells.
In addition, we probed global transcriptional changes using RNA-
seq to determine the response to 103Q and 230Q expression. PolyQ
expression was induced for a total of 30 hr before RNA extraction and
sequencing. Surprisingly, very few gene expression differences were
observed between wild-type, 103Q and 230Q data sets (Figure 3B).
Indeed, in each of three replicates performed, the correlation coefﬁcient
between any two samples remained above 0.88 (Figure S3), with few
genes being up or downregulated in any of the conditions tested (File
S1). The data document that expression of polyQ proteins has little or
no effect on gene expression in C. albicans.
Figure 4 Deletion of polyQ protein inter-
actors does not increase toxicity or aggre-
gation. (A) Protein interactors of 230Q.
Histogram depicting the normalized total
spectra count of proteins found to interact
with 230Q in two biological replicates
(230Q-1 and 230Q-2). (B) Toxicity in wild-
type (WT) and independent sis1D/sis1D or
sgt2D/sgt2D mutants, harboring 103Q or
230Q expression constructs, was assessed
in the presence of a tunicamycin (Tm) gra-
dient from 0 to 10 mg/ml, in twofold dilu-
tions in YPD with or without 50 mg/ml
doxycycline (dox) at 30 or 42. Growth
was measured after 48 hr of static incuba-
tion by absorbance at 600 nm and normal-
ized relative to the no Tm control. For each
strain, optical densities were averaged for
duplicate measurements and displayed
quantitatively using Treeview, as shown in
the color bar. Data are representative for
three biological replicates. (C) Live cell mi-
croscopy of 103Q and 230Q in sis1D/sis1D
or sgt2D/sgt2Dmutants grown at 42. Scale
bar, 10 mm. (D) Toxicity of WT and inde-
pendent hsp104D/hsp104D or ubi4D/ubi4D
mutants harboring 103Q or 230Q expres-
sion constructs was assessed in the pres-
ence of a Tm gradient from 0 to 10 mg/ml,
in twofold dilutions in YPD with or with-
out 50 mg/ml dox at 30 or 42. Growth was
measured after 48 hr of static incubation by
absorbance at 600 nm and normalized rel-
ative to the no Tm control. For each strain,
optical densities were averaged for dupli-
cate measurements and displayed quantita-
tively using Treeview, as shown in the color
bar. Data are representative for three bio-
logical replicates. (E) Live cell microscopy of
103Q and 230Q in hsp104D/hsp104D or
ubi4D/ubi4D mutants grown at 42. Scale
bar, 10 mm. DIC, differential interference
contrast; RFP, red ﬂuorescent protein.
104 | M. D. Leach et al.
Sis1 and Sgt2 interact with polyglutamine-
expanded Htt
The negligible transcriptional response to polyQ expansions suggested
that C. albicans cells cope with high levels of polyQ proteins with
minimal changes in gene expression programs. Therefore, we ex-
plored amass spectrometry-based approach to determine which proteins
interact with the polyQ proteins using 230Q as an example. IP-mass
spectrometry showed that only eight proteins are enriched in the 230Q
strain upon induction of the polyQ expansion, compared to the unin-
duced condition and the wild-type strain (Table 2). Interestingly, the
molecular chaperones Sgt2 and Sis1 had among the strongest interactions
with the 230Q expansion (Figure 4A). Sgt2 has previously been impli-
cated as an amyloid sensor, regulating the targeting of chaperones to
aggregation-prone proteins in S. cerevisiae (Kiktev et al. 2012). Further-
more, Sis1 has recently been found to be sequestered by polyQ aggre-
gates, which in turn inhibits degradation of misfolded proteins via the
ubiquitin–proteasome system (Park et al. 2013). To determine if these
proteins prevent polyQ aggregation and toxicity, we generated deletion
mutants for each of them in C. albicans, and expressed our 103Q and
230Q expansions. We then tested polyQ toxicity using a growth assay
with an increasing concentration of tunicamycin at either 30 or 42
(Figure 4B). In both sis1 and sgt2 deletion mutants, no polyQ toxicity
was observed compared to wild-type strains (Figure 4B). We also ex-
plored polyQ aggregation via ﬂuorescence microscopy after growth at
42 (Figure 4C). We found that the 103Q expansion remains evenly
distributed throughout the cell, indicative of a soluble polyQ protein.
Yet when the 230Q expansion is expressed at higher temperatures, we
observe a few punctate structures forming, indicative of aggregation,
similar to our experiment in heat-shocked wild-type cells (Figure S2A).
Next, we tested the impact of additional key regulators of protein
homeostasis on polyQ toxicity and aggregation. Given the established
role of Hsp104 in modulating polyQ aggregation and toxicity, we
assessed the impact of HSP104 deletion in C. albicans on the aggrega-
tion and toxicity of 103Q and 230Q. In addition, we postulated that the
ubiquitin-proteasome pathway may also play a role by targeting the
expansions for efﬁcient degradation, preventing any cellular toxicity.
Thus, we also used a deletion ofUBI4, the gene encoding polyubiquitin.
Once again, we subjected the strains to ER stress via tunicamycin
treatment and performed growth assays at 30 or 42. Notably, the
ubi4D/ubi4D is temperature-sensitive, and we could only test this mu-
tant at 30 (Leach et al. 2011). As with SIS1 and SGT2, deletion of
HSP104 or UBI4 did not exacerbate growth defects upon expression
of 103Q and 230Q (Figure 4D). Again, we performed ﬂuorescence
microscopy to determine if any further aggregation was occurring in
themutants. Cells were grown at 42 for a short period of time to ensure
that viability of the temperature-sensitivemutants was not affected, and
then cells were imaged. Similar to our other mutants, 103Q remained
evenly distributed across the cytosol and 230Q formed few punctate
structures (Figure 4E).
Finally, we corroborated these data by performing SDD-AGE assays
in each of the deletion strains at 30 and 42. PolyQ expansions were
induced in strains grown for 24 hr, followed by subculturing for an
additional 6 hr at 30 or 42. At 30, polyQ aggregates were observed in
the S. cerevisiae 103Q expressing rnqD and [RNQ+] strains, but not in
any of the C. albicans strains (Figure 5). However, there was consider-
able aggregation observed in most of our C. albicans mutants express-
ing 230Q grown at 42, as well as in the hsp104D/hsp104D mutant
expressing 103Q. Due to the temperature sensitivity of S. cerevisiae,
aggregation of our C. albicans mutants at 42 was compared to our S.
cerevisiae strains grown at 30, whereby we still observed signiﬁcantly
lower levels of aggregation (Figure 5).
DISCUSSION
PolyQexpansionproteins, theirmisfolding, aggregation, and toxicity
are closely associated with at least nine neurodegenerative diseases
(Fan et al. 2014). In addition, polyQ expansion proteins have suc-
cessfully served as experimental paradigms to explore basic mech-
anisms by which cellular defense systems modulate the toxicity
often associated with protein misfolding. Following this logic, we
established a C. albicans model expressing polyQ expansion pro-
teins to gain insights into the protein quality control system and
stress response programs of this major human fungal pathogen.
However, we found that the expression of amino-terminal frag-
ments of a polyQ-expanded huntingtin protein (103Q and 230Q)
in C. albicans does not share any of the previously established bio-
chemical and cellular hallmarks of polyQ expansion proteins and
their interactions with cellular protein control systems.
The amino acid sequence of a protein determines its propensity to
misfold and aggregate, with sequences rich in asparagine and glutamine
favoring aggregation (Alberti et al. 2009). Indeed, in S. cerevisiae, cultured
mammalian cells, D. melanogaster, C. elegans, rodents, and many other
models, expression of polyQ expansion proteins leads to considerable
aggregation in the cytosol or the nucleus (Brignull et al. 2006; Bradford
et al. 2010; Faber et al. 1999; Jackson et al. 1998; Duennwald et al. 2006b;
Duennwald 2011), which is often accompanied by reduced cellular and
organismal ﬁtness due to impaired core cellular functions, particularly
those involved in protein quality control. Strikingly, our ﬁndings clearly
demonstrate that C. albicans cells expressing polyQ expansion proteins
had no polyQ aggregation under basal physiological conditions, and
there was negligible polyQ toxicity or transcriptional response, with the
HSR also being unaffected. This result is striking given that the C. albi-
cans polyQ constructs are expressed at higher levels than the correspond-
ing polyQ constructs in S. cerevisiae (Figure 2D).
Figure 5 Expression of up to 230Q in mutants involved in protein
quality control does not cause aggregation in C. albicans. Semidena-
turating detergent agarose gel electrophoresis analysis of aggregated
proteins expressed from C. albicans wild type (WT) and different mu-
tant backgrounds harboring 103Q or 230Q expression constructs at
30 (top) vs. 42 (bottom). S. cerevisiae 103Q in rnqD and [RNQ+] were
grown at 30 only and were included as a control. Detection via the
N-terminal FLAG-tag.
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This lack of toxicity associated with polyQ expansions resonates with
recent ﬁndings in D. discoideum, an organism with a proteome that is
highly enriched in polyN and polyQ proteins (Malinovska et al. 2015;
Santarriaga et al. 2015). In D. discoideum, polyQ aggregation could only
be induced by exposure to strong proteotoxic stress conditions, such as a
heat shock. This was interpreted as evidence that organisms with pro-
teomes enriched in aggregation-prone proteins, such as polyQ expansion
proteins, have evolved highly effective protein quality control systems to
prevent the toxic consequences of protein misfolding. Notably, our re-
sults in C. albicans, along with studies performed in other organisms,
such as S. pombe and D. melanogaster, do not fall in line with this
correlation. Unlike D. discoideum, the proteome of C. albicans does
not have a high proportion of aggregation-prone proteins (polyQ expan-
sion and other proteins) (Figure 6), and S. pombe contains very few
aggregation-prone proteins in its proteome (Schaefer et al. 2012). Yet
both yeasts show little to no polyQ aggregation and polyQ toxicity. In
fact, even when we challenge C. albicans protein quality control systems
by genetic manipulation or exposure to proteotoxic stress conditions, C.
albicans exhibits little polyQ aggregation and no polyQ toxicity. Further,
the proteome of D. melanogaster, similar to the proteome of D.
discoideum, is highly enriched in Q- and N-rich aggregation-prone pro-
teins (Schaefer et al. 2012). Yet unlike D. discoideum, the expression of
polyQ expansion proteins results in polyQ aggregation and toxicity in ﬂy
cells (Jackson et al. 1998). PolyQ-expanded proteins engage in many
unusually stable protein–protein interactions and often sequester other
proteins rich in N or Q repeats, which can impair their functions, result-
ing in cellular toxicity (Duennwald et al. 2006a; Kochneva-Pervukhova
et al. 2012; Lessing and Bonini 2008; Kayatekin et al. 2014). However, the
proteomes of C. albicans and S. cerevisiae do not differ signiﬁcantly in
the proportions of Q- or N-rich proteins in their proteasomes (Figure 6).
In fact, our IP-mass spec experiments identiﬁed only eight proteins that
interact with 230Q in C. albicans, only one of which is N- or Q-rich
(Table 2). Some interactions may have been missed due to technical
challenges associated with aggregation-prone proteins, however, the lack
of polyQ aggregation and toxicity in C. albicans suggests minimal func-
tional consequences. Clearly, there is no simple correlation between the
proportion of aggregation-prone proteins in the proteome of a given
organism and resistance to polyQ aggregation and toxicity.
We further explored the resistance of C. albicans to polyQ aggre-
gation and toxicity by directly targeting major chaperone pathways
with central roles in protein quality control. We found that the chap-
erones Sis1 and Sgt2 interact with 230Q in C. albicans. These chaper-
ones are known to assist protein folding, prevent aggregation, and
target misfolded proteins for proteolytic degradation (Verghese et al.
2012). Sgt2 and its mammalian homolog, SGTA, are recruited into
polyglutamine aggregates in S. cerevisiae and in mammalian cells, re-
spectively (Wear et al. 2015;Wang et al. 2007). Sgt2 may regulate prion
propagation by modulating interactions of Hsp104 andHsp70 proteins
with prion polymers (Kiktev et al. 2012), and may positively regulate
polyQ expansions in S. cerevisiae. Yet the deletion of SGT2 in C. albi-
cans did not exacerbate aggregation or toxicity of polyQ expression
(Figure 4, B and C). In S. cerevisiae, the Hsp40 chaperone Sis1 interacts
with soluble polyQ species and transports polyQ aggregates, along with
other misfolded proteins, to the nucleus for proteasomal degradation
(Park et al. 2013). Depletion of SIS1 in S. cerevisiae causes protein
misfolding and aggregation in the cytosol (Park et al. 2013). Yet again,
we found that deletion of SIS1 coupled with polyQ expression had no
effect on protein aggregation, solubility, or toxicity in C. albicans (Fig-
ure 4, B and C). Finally, even exposing C. albicans to geldanamycin to
inhibit Hsp90 during expression of our polyQ-expanded Htt had no
effect on toxicity (Figure 2C). Likewise, deletion of HSP104, a major
fungal disaggregase, had no effect on polyQ aggregation, solubility, or
toxicity (Figure 4, D and E and Figure 5).
Our results, combined with data from other model organisms,
reveals a perplexing interplay between protein quality control systems,
polyQ aggregation, and toxicity, and possibly more global aspects of
protein misfolding. Our ﬁndings suggest that C. albicans has evolved
powerful mechanisms to control protein aggregation during normal
growth conditions and upon stress. Systematic analysis of aggregation
and toxicity associated with polyQ expansion proteins, prions, and
n Table 2 PolyQ interactors
Protein Role PolyQ PolyN
Sis1 Putative type II HSP40 cochaperone N/A N/A
Sgt2 Putative small tetratricopeptide
repeat (TPR)-containing protein
N/A N/A
Hap2 CCAAT-binding transcription factor;
regulates low-iron induction of
FRP1
13 9
Tbp1 Transcription initiation factor; binds
TATA box sequence
N/A N/A
Pfa4 Palmitoyltransferase with
autoacylation activity; required
for palmitoylation of amino acid
permeases
N/A N/A
Tim17 Predicted component of the
Translocase of the Inner
Mitochondrial membrane (TIM23
complex), involved in protein
import into mitochondria
N/A N/A
Rad51 Protein involved in homologous
recombination and DNA repair
N/A N/A
Orf19.11473 Ortholog(s) have DNA-directed
RNA polymerase activity, RNA
polymerase III activity and role
in tRNA (transfer RNA) transcription
from RNA polymerase III promoter,
transcription initiation from RNA
polymerase III promoter
N/A N/A
N/A, not applicable.
Figure 6 Bioinformatic analysis reveals similar features between S.
cerevisiae and C. albicans Q/N-rich proteome. Length distribution of
glutamine and asparagine runs in S. cerevisiae and C. albicans, with
both species containing one protein with #40 glutamines in a row
or #30 asparagines in a row.
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other proteins with a high propensity to misfold across different
organisms and cell types will be central to elucidating fundamental
mechanisms that have evolved across the tree of life to mitigate
proteotoxicity.
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